Metraipolis › archive › dc_a98145bb63ce

The global impact of imiglucerase therapy in children with Gaucher disease types 1 and 3: a real-world analysis from the International Collaborative Gaucher… — Europe PMC PMID:41821052

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41821052
DOI: 10.1186/s13023-[numero omesso]-w
License (as archived): solo-consultazione
Archived: 2026-11-04T20:04:00.532Z
SHA-256 of the archived text: 22d8ec79f7d80a5cd786b46ec2c603dadf3e5843db0f1cd8d427e06d23a92f93
Stable URL of this page: https://metraipolis.com/documento/dc_a98145bb63ce

How to cite

The global impact of imiglucerase therapy in children with Gaucher disease types 1 and 3: a real-world analysis from the International Collaborative Gaucher… — Europe PMC PMID:41821052 — Europe PMC (en), https://europepmc.org/article/MED/41821052 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_a98145bb63ce (Metraipolis archive dc_a98145bb63ce, sha256 22d8ec79f7d80a5cd786b46ec2c603dadf3e5843db0f1cd8d427e06d23a92f93)

BibTeX

@misc{dca98145bb63ce,
  title = {The global impact of imiglucerase therapy in children with Gaucher disease types 1 and 3: a real-world analysis from the International Collaborative Gaucher… — Europe PMC PMID:41821052},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41821052},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_a98145bb63ce; sha256 22d8ec79f7d80a5cd786b46ec2c603dadf3e5843db0f1cd8d427e06d23a92f93},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41821052. Agents can read the archived copy with the MCP tool read_document.